About John Williamson III
Form D filings for Chorda Pharma in 2024 list John Williamson III as director.
John Williamson III first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name John Williamson III in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people John Williamson III works with at each company, as listed on that company's latest Form D.
Chorda Pharma, Inc. · Form D, Dec 20, 2024
GJ
George Vaughan, Jr.
Director
AH
Aileen Helsel
Director
RC
Richard Carliss
Executive officer, director and promoter
VI
Victor Iannello
Chief Executive Officer and director